Q3 2025 Treace Medical Concepts Inc Earnings Call Transcript
Key Points
- Treace Medical Concepts Inc (TMCI) reported third quarter revenues of $50.2 million, representing an 11% growth over the third quarter of 2024.
- The company achieved a 49% improvement in adjusted EBITDA compared to the prior year.
- TMCI has developed and commercialized three new bunion correction systems, expanding its product portfolio.
- The company has added a Chief Commercial Officer and a new Senior Vice President of Sales to strengthen its sales team.
- Over 20% of TMCI's surgeon customers have adopted one or more of the new bunion technologies within one quarter of launch.
- TMCI experienced pressure on lapoplasty volumes as surgeon and patient preferences shifted towards minimally invasive osteotomies.
- Broader economic conditions and softer consumer sentiment have led to a greater number of deferrals of elective bunion procedures.
- The company revised its full-year revenue outlook to a growth of only 1% to 2% compared to 2024.
- TMCI recorded a net loss of $16.3 million in the third quarter, an increase from the previous year's net loss.
- The shift in product mix towards lower ASP systems has impacted overall revenue levels.
Good day and thank you for standing by.
Welcome to the Tres Medical Concepts, 3rd quarter, 2025 earnings conference call.
At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question-and-answer session. To ask a question during the session, you will need to press 11 on your telephone. You will then hear an automated message advising your hand is raised. To withdraw your question, please press star 11 again.
We ask that all analysts please limit themselves to one question and one follow-up.
Please be advised that today's conference is being recorded. I would now like to hand the conference over to your first speaker today, Trip Taylor, investor relations. Please go ahead.
One moment, please. Please stand by.
Good afternoon everyone and welcome to our 3rd quarter 2025 earnings conference call. Participating from the company today will be John Treese, Chief Executive Officer, and Mark Hare, Chief
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
